Focal Therapeutics Company Profile
Focal Therapeutics is a medical device company based in Silicon Valley. The company’s first product is the BioZorb™ tissue marker, a bioabsorbable device that provides radiographic marking of soft tissue sites. The BioZorb device is placed at the time of surgical removal of tissue, such as during breast surgery, and the device’s three-dimensional array of marker elements has utility for clinical imaging. Focal Therapeutics is led by a seasoned team with a proven track record in the successful development and commercialization of medical products.
News Articles
Focal Upright Furniture Announces ErgoDepot as First Retail Partner
Portsmouth, R.I. (PRWEB) February 02, 2013 Focal Upright Furniture is pleased to announce that Ergo Depot, headquartered in Portland, OR, has become Focal Upright’s first retail partner....
EDAP Introduces Focal.One(R): A New Robotic HIFU Device for Focal Therapy of Prostate Cancer
LYON, France, March 14, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the launch of Focal.One®, its new and innovative robotic HIFU...
Unanchoring integrins in focal adhesions
Focal adhesions are large structures through which integrins and scaffold proteins link the actin cytoskeleton to the extracellular matrix. A detailed analysis of integrin dynamics now indicates that...
Prostate focused ultrasound focal therapy—imaging for the future
Treatment of prostate cancer using high-intensity focused ultrasound (HIFU) focal therapy could be a reliable treatment option but, are we ready for it? This Perspectives article assesses whether our...
Mutations of DEPDC5 cause autosomal dominant focal epilepsies
Stéphanie Baulac and colleagues report the identification of mutations in the DEPDC5 gene that cause focal epilepsies.
Integrins β1 and β3 exhibit distinct dynamic nanoscale organizations inside focal adhesions
Giannone and colleagues use super-resolution microscopy to analyse the nanoscale dynamic organization of talin and integrins β1 and β3 in focal adhesions.
MRI-Guided Focal Laser Therapy for Low-Risk Prostate Cancer
The name of the featured clinical trial is MRI-Guided Focal Therapy in Prostate Cancer (NCI-11-C-0158).
Further research needed into therapeutic potential of rTMS for focal hand dystonia
Repetitive transcranial magnetic stimulation (rTMS) is being increasingly explored as a therapeutic tool for movement disorders associated with deficient inhibition throughout the central nervous syst...
Drugs and Medications
Temodar [Schering Corporation]
These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR (temozolomide) CapsulesTEMODAR (temozolomide) fo...
Temodar [Physicians Total Care, Inc.]
These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR (temozolomide) CapsulesTEMODAR (temozolomide) fo...
PubMed Articles
The X-ray source or focal radiation is one of the factors that can degrade the conformal field edge in stereotactic body radiotherapy. For that reason, it is very important to estimate the total focal...
Mechanotransduction and Focal Adhesions.
Cellular focal adhesions respond to internal and external mechanical stresses, making them prime candidates for mechanotransduction. Recent observations have shown that the focal adhesion proteins, in...
The effects of protein type and pattern size on cell adhesion, spreading, and focal adhesion development are studied. Fibronectin and vitronectin patterns from 0.1 to 3ÎĽm produced by colloidal lithog...
Genetic evidence for an association of the TOR1A locus with segmental/focal dystonia.
Polymorphisms in the TOR1A/TOR1B region have been implicated as being associated with primary focal and segmental dystonia. In a cohort of subjects with either focal or segmental dystonia affecting th...
The adaptor protein SH2B1β participates in regulation of the actin cytoskeleton during processes such as cell migration and differentiation. Here, we identify SH2B1β as a new focal adhesion protein....
Clinical Trials
Survey of Sensory and Motor Tricks in Focal Dystonia
This study will collect information on (tricks) patients with focal dystonia use to relieve their symptoms. Dystonia is a movement disorder caused by sustained muscle contractions often c...
Dystonia is a neurological movement disorder in which sustained muscle contractions cause twisting and repetitive movements or abnormal postures. This disease is very heterogeneous and can...
A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis
The purpose of this study is to assess the safety, tolerability and effectiveness of rituximab in the treatment of chronic focal encephalitis.
Amlodipine Plus Botulinum Toxin for Focal Dystonia
Objective: To determine if the calcium channel blockers, amlodipine can augment the effect of botulinum toxin injections in the treatment of focal dystonia. Study Population: 20 patien...
The purpose of this study is to evaluate the safety and tolerability of FG-3019 administered over 8 weeks to adolescent and adult subjects with steroid-resistant focal segmental glomerulos...
Companies
Focal Therapeutics is a medical device company based in Silicon Valley. The company’s first product is the BioZorb™ tissue marker, a bioabsorbable device that provides r...
StaffPointe has evolved over time to become one of the most visited medical and healthcare employment destinations online today. We have spent most of our efforts refining and improving our online pre...
CureFAKtor Pharmaceuticals, LLC
CureFAKtor Pharmaceuticals is a biopharmaceutical company focused on the research and development of Focal Adhesion Kinase therapies to prevent or treat cancer. CureFAKtor's investigational and combin...
Retrophin, LLC is a privately-held New York-based, biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases. Retrophin is curr...
Retrophin is a biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases. Retrophin is currently developing treatments for foca...
More Information about "Focal Therapeutics" on BioPortfolio
We have published hundreds of Focal Therapeutics news stories on BioPortfolio along with dozens of Focal Therapeutics Clinical Trials and PubMed Articles about Focal Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Focal Therapeutics Companies in our database. You can also find out about relevant Focal Therapeutics Drugs and Medications on this site too.
